Codon Devices, Inc., based in Cambridge, MA, is a privately-held biotechnology company focused on enabling commercial applications of synthetic biology. Codon Devices’ proprietary synthesis and design technologies improve the productivity of its industrial, pharmaceutical and academic customers in a paradigm shift to what the Company calls Constructive Biology™. The Company’s focus is on developing and delivering high-value products and design services in a variety of application areas, including engineered gene libraries, engineered cells that produce novel pharmaceuticals, improved vaccines, agricultural products, and biorefineries for the production of industrial chemicals and energy.
Financials
| Date | Type | Amount | Investors | Valuation |
|---|---|---|---|---|
| 12/01/06 | Series B | 20M | Camden Partners, Torch Hill Investment Partners, WashingtonVC, Odyssey Capital Group, Palisades Ventures | Unknown |
People
Bob Higgins (Head of Creative)
Michael Hunkapiller (Board Member)
Joseph Jacobson (Board Member)
Joe Lacob (Board Member)
Brian Baynes (Founder & President)
News
Life-science briefing: Monday, March 31, 2008
March 31, 2008 4:00 pm
TODAY’S HEADLINES: Boston Scientific spinout TriVascular2 takes in $65M (release) Inhaled-drug startup Transave raises $35M (release) Triage Wireless gets $20M… Continue reading ⟩
Synthetic Genomics to create new forms of life
December 30, 2005 9:45 am
Start-up Synthetic Genomics launched in June, and wants to create new forms of life. The idea is far enough “out… Continue reading ⟩